retrospective study
OtherRetrospective study
NCT Number: NCT05472376
The goal of this study is to evaluate the real-world outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment in diabetic macular edema (DME) patients.
Looking for future studies?
Notify MeObservational
Kocaeli University School of Medicine, Kocaeli, None Selected, Turkey (Türkiye)
The study included patients who were being observed in the retina departments of 8 tertiary hospitals in the Northern Marmara Region of Turkey (Istanbul's Asian Side, Kocaeli, and Sakarya). The records of DME patients treated with an anti-VEGF agent between January 2015 and December 2018 were reviewed.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Retrospective study
Time frame: First year
The primary outcomes were changes in best-corrected visual acuity and central macular thickness in the first year and frequency of visits and intravitreal anti-VEGF injections.
Kocaeli University
Other
Real-World Outcomes of Anti-VEGF Treatment for Diabetic Macular Edema in Turkey: A Multicenter Retrospective Study, MARMASIA Study Group
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04516278
Age-Related Macular Degeneration, BRVO - Branch Retinal Vein Occlusion
Tucson, Arizona, United States
View Trial DetailsNCT04772105
Diabetic Macular Edema
Beijiang, Beijing Municipality, China
View Trial DetailsNCT06850922
Diabetic Macular Edema
Phoenix, Arizona, United States
View Trial DetailsNCT04597918
Diabetic Macular Edema
Naples, Florida, United States
View Trial Details